These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats. Tanaka A, Kunikata T, Mizoguchi H, Kato S, Takeuchi K. J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470 [Abstract] [Full Text] [Related]
7. Soluble Dietary Fibers Can Protect the Small Intestinal Mucosa Without Affecting the Anti-inflammatory Effect of Indomethacin in Adjuvant-Induced Arthritis Rats. Satoh H, Matsumoto H, Hirakawa T, Wada N. Dig Dis Sci; 2016 Jan; 61(1):91-8. PubMed ID: 26423078 [Abstract] [Full Text] [Related]
8. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility. Satoh H, Amagase K, Takeuchi K. J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201 [Abstract] [Full Text] [Related]
10. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Takeuchi K, Miyazawa T, Tanaka A, Kato S, Kunikata T. Digestion; 2002 Nov; 66(1):30-41. PubMed ID: 12379813 [Abstract] [Full Text] [Related]
11. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs. Takeuchi K, Yokota A, Tanaka A, Takahira Y. Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022 [Abstract] [Full Text] [Related]
12. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats. Konaka A, Kato S, Tanaka A, Kunikata T, Korolkiewicz R, Takeuchi K. Pharmacol Res; 1999 Dec; 40(6):517-24. PubMed ID: 10660951 [Abstract] [Full Text] [Related]
13. Increased susceptibility of small intestine to NSAID-provoked ulceration in rats with adjuvant-induced arthritis: involvement of enhanced expression of TLR4. Kato S, Ito Y, Nishio H, Aoi Y, Amagase K, Takeuchi K. Life Sci; 2007 Sep 29; 81(16):1309-16. PubMed ID: 17920637 [Abstract] [Full Text] [Related]
17. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. Konaka A, Nishijima M, Tanaka A, Kunikata T, Kato S, Takeuchi K. J Physiol Pharmacol; 1999 Mar 29; 50(1):25-38. PubMed ID: 10210152 [Abstract] [Full Text] [Related]
18. Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin. Anthony A, Pounder RE, Dhillon AP, Wakefield AJ. Gut; 1997 Dec 29; 41(6):763-70. PubMed ID: 9462208 [Abstract] [Full Text] [Related]
19. Contribution to safe anti-inflammatory therapy with indomethacin. Bauerová K, Nosál'ová V, Mihalová D, Navarová J. Cent Eur J Public Health; 2004 Mar 29; 12 Suppl():S8-10. PubMed ID: 15141962 [Abstract] [Full Text] [Related]
20. Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic. Fornai M, Antonioli L, Pellegrini C, Colucci R, Sacco D, Tirotta E, Natale G, Bartalucci A, Flaibani M, Renzulli C, Ghelardi E, Blandizzi C, Scarpignato C. Pharmacol Res; 2016 Feb 29; 104():186-96. PubMed ID: 26747402 [Abstract] [Full Text] [Related] Page: [Next] [New Search]